The cannabis industry is witnessing significant growth as state-level legalization expands and consumer demand rises. This shift from a contentious issue to a legitimate market opens up diverse investment opportunities, from producers to ancillary service providers. The potential federal rescheduling of cannabis could catalyze further industry expansion by allowing more research and funding. As societal acceptance increases, there is a broader appeal for cannabis products, particularly for medical purposes, contributing to job creation and a thriving market.
Currently, cannabis is classified as a Schedule I substance, meaning it's considered to have no medical use and a high potential for abuse.
The demand for products like edibles, oils, tinctures, and wellness products continues to grow, as the stigma surrounding marijuana use diminishes.
Collection
[
|
...
]